BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30670564)

  • 1. Breast specimen handling and reporting in the post-neoadjuvant setting: challenges and advances.
    Mrkonjic M; Berman HK; Done SJ; Youngson B; Mulligan AM
    J Clin Pathol; 2019 Feb; 72(2):120-132. PubMed ID: 30670564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Perfect Pathology Report After Neoadjuvant Therapy.
    Marchiò C; Maletta F; Annaratone L; Sapino A
    J Natl Cancer Inst Monogr; 2015 May; 2015(51):47-50. PubMed ID: 26063886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardizing of Pathology in Patients Receiving Neoadjuvant Chemotherapy.
    Bossuyt V; Symmans WF
    Ann Surg Oncol; 2016 Oct; 23(10):3153-61. PubMed ID: 27380637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group.
    Provenzano E; Bossuyt V; Viale G; Cameron D; Badve S; Denkert C; MacGrogan G; Penault-Llorca F; Boughey J; Curigliano G; Dixon JM; Esserman L; Fastner G; Kuehn T; Peintinger F; von Minckwitz G; White J; Yang W; Symmans WF;
    Mod Pathol; 2015 Sep; 28(9):1185-201. PubMed ID: 26205180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological assessment of resection specimens after neoadjuvant therapy for metastatic melanoma.
    Tetzlaff MT; Messina JL; Stein JE; Xu X; Amaria RN; Blank CU; van de Wiel BA; Ferguson PM; Rawson RV; Ross MI; Spillane AJ; Gershenwald JE; Saw RPM; van Akkooi ACJ; van Houdt WJ; Mitchell TC; Menzies AM; Long GV; Wargo JA; Davies MA; Prieto VG; Taube JM; Scolyer RA
    Ann Oncol; 2018 Aug; 29(8):1861-1868. PubMed ID: 29945191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Processing and Reporting of Breast Specimens in the Neoadjuvant Setting.
    Bossuyt V
    Surg Pathol Clin; 2018 Mar; 11(1):213-230. PubMed ID: 29413658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of Standardization in the Processing and Reporting of Post-Neoadjuvant Breast Cancer Specimens.
    Han R; Regpala S; Slodkowska E; Nofech-Mozes S; Hanna W; Parra-Herran C; Lu FI
    Arch Pathol Lab Med; 2020 Oct; 144(10):1262-1270. PubMed ID: 32142368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological controversies in breast cancer: classification of ductal carcinoma in situ, sentinel lymph nodes and low volume metastatic disease and reporting of neoadjuvant chemotherapy specimens.
    Provenzano E; Brown JP; Pinder SE
    Clin Oncol (R Coll Radiol); 2013 Feb; 25(2):80-92. PubMed ID: 23199579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macroscopic handling and reporting of breast cancer specimens pre- and post-neoadjuvant chemotherapy treatment: review of pathological issues and suggested approaches.
    Pinder SE; Rakha EA; Purdie CA; Bartlett JM; Francis A; Stein RC; Thompson AM; Shaaban AM;
    Histopathology; 2015 Sep; 67(3):279-93. PubMed ID: 25585651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology of breast carcinomas after neoadjuvant chemotherapy: an overview with recommendations on specimen processing and reporting.
    Sahoo S; Lester SC
    Arch Pathol Lab Med; 2009 Apr; 133(4):633-42. PubMed ID: 19391665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ever-evolving role of pathologists in the management of breast cancer with neoadjuvant treatment: recommendations based on the Spanish clinical experience.
    Burgués O; López-García MÁ; Pérez-Míes B; Santiago P; Vieites B; García JF; Peg V
    Clin Transl Oncol; 2018 Mar; 20(3):382-391. PubMed ID: 28795336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory handling and histology reporting of breast specimens from patients who have received neoadjuvant chemotherapy.
    Pinder SE; Provenzano E; Earl H; Ellis IO
    Histopathology; 2007 Mar; 50(4):409-17. PubMed ID: 17448015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Examination and pathology reporting of specimens from breast conservation therapy].
    Zhang JX
    Zhonghua Bing Li Xue Za Zhi; 2012 May; 41(5):292-5. PubMed ID: 22883665
    [No Abstract]   [Full Text] [Related]  

  • 14. Diffuse optical spectroscopic imaging correlates with final pathological response in breast cancer neoadjuvant chemotherapy.
    Cerussi AE; Tanamai VW; Hsiang D; Butler J; Mehta RS; Tromberg BJ
    Philos Trans A Math Phys Eng Sci; 2011 Nov; 369(1955):4512-30. PubMed ID: 22006904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardization of pathologic complete response rates in breast cancer treatment.
    Knauer M; Devries A; Wenzl E; Haid A
    Breast Cancer Res Treat; 2008 Jul; 110(2):395-6. PubMed ID: 17851755
    [No Abstract]   [Full Text] [Related]  

  • 16. Role and evaluation of pathologic response in early breast cancer specimens after neoadjuvant therapy: consensus statement.
    Guerini-Rocco E; Botti G; Foschini MP; Marchiò C; Mastropasqua MG; Perrone G; Roz E; Santinelli A; Sassi I; Galimberti V; Gianni L; Viale G
    Tumori; 2022 Jun; 108(3):196-203. PubMed ID: 34918596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathologic response and long-term follow-up in breast cancer patients treated with neoadjuvant chemotherapy: a comparison between classifications and their practical application.
    Corben AD; Abi-Raad R; Popa I; Teo CH; Macklin EA; Koerner FC; Taghian AG; Brachtel EF
    Arch Pathol Lab Med; 2013 Aug; 137(8):1074-82. PubMed ID: 23899063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New treatment sequence protocol to reconstruct locally advanced breast cancer.
    Tansley P; Ramsey K; Wong S; Guerrieri M; Pitcher M; Grinsell D
    ANZ J Surg; 2013 Sep; 83(9):630-5. PubMed ID: 23496238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proposals for uniform collection of biospecimens from neoadjuvant breast cancer clinical trials: timing and specimen types.
    Loi S; Symmans WF; Bartlett JM; Fumagalli D; Van't Veer L; Forbes JF; Bedard P; Denkert C; Zujewski J; Viale G; Pusztai L; Esserman LJ; Leyland-Jones BR
    Lancet Oncol; 2011 Nov; 12(12):1162-8. PubMed ID: 21684810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammographically directed breast biopsies: a College of American Pathologists Q-Probes study of clinical physician expectations and of specimen handling and reporting characteristics in 434 institutions.
    Nakhleh RE; Jones B; Zarbo RJ
    Arch Pathol Lab Med; 1997 Jan; 121(1):11-8. PubMed ID: 9111087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.